‎Saudi German Health sees revenue growth in 2026, margins to slightly improve

‎Saudi German Health sees revenue growth in 2026, margins to slightly improve ‎Saudi German Health sees revenue growth in 2026, margins to slightly improve

​‎

Saudi German Health CEO Nizar Bahabri expectssales to continue growingthrough 2026,despite anticipating a relative slowdown in Q1 2026 due to seasonal factors.

Middle East Healthcare Co.’s (SaudiGerman Health) management expects revenue to continue growth through 2026, alongside gradual improvement in profit margins, despite anticipating a relative slowdown in Q1 2026 due to seasonal factors, CEONizar Bahabri told Argaam.

Advertisement

Bahabri indicated that Q1 2026 would fully include the holy month of Ramadan and Eid Al-Fitr, while they fell partially in Q1 2025.
Q4 2025 results included losses of SAR 11 million related to Sobhi Abdul Jalil Batterjee Hospital, which commenced operations during the same quarter, and in which Saudi German Health holds a 22% stake.
Q4 2024 included non-recurring exceptional gains of SAR 45 million resulting from Zakat restructuring. Excluding non-recurring items in both periods, adjusted net profit declined by only 28%.
The 8% revenue growth in Q4 was not fully reflected in net profit due to higher operating expenses associated with expansion plans, as more than 400 Saudi specialized physicians were recruited in 2025 to work across the group’s hospitals.

 

Saudi German Health CEO Nizar Bahabri expectssales to continue growingthrough 2026,despite anticipating a relative slowdown in Q1 2026 due to seasonal factors.

Middle East Healthcare Co.’s (SaudiGerman Health) management expects revenue to continue growth through 2026, alongside gradual improvement in profit margins, despite anticipating a relative slowdown in Q1 2026 due to seasonal factors, CEONizar Bahabri told Argaam.

Bahabri indicated that Q1 2026 would fully include the holy month of Ramadan and Eid Al-Fitr, while they fell partially in Q1 2025.
Q4 2025 results included losses of SAR 11 million related to Sobhi Abdul Jalil Batterjee Hospital, which commenced operations during the same quarter, and in which Saudi German Health holds a 22% stake.
Q4 2024 included non-recurring exceptional gains of SAR 45 million resulting from Zakat restructuring. Excluding non-recurring items in both periods, adjusted net profit declined by only 28%.
The 8% revenue growth in Q4 was not fully reflected in net profit due to higher operating expenses associated with expansion plans, as more than 400 Saudi specialized physicians were recruited in 2025 to work across the group’s hospitals.
Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with our Weekly Newsletter

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement